A股異動 | 雙良節能漲近5% 與新特能源簽訂585億多晶硅採購大單
格隆匯7月13日丨雙良節能(600481.SH)漲4.92%,報17.9元,總市值291億元。雙良節能12日公吿,全資子公司雙良硅材料(包頭)有限公司近期與新特能源股份有限公司、新疆新特晶體硅高科技有限公司、內蒙古新特硅材料有限公司、新特硅基新材料有限公司簽訂了《多晶硅戰略合作買賣協議書》,合同約定2023年至2030年買方預計向賣方採購多晶硅料20.19萬噸,預計採購金額約為584.70億元(含税,本測算價格不構成價格承諾)。雙方約定,實際採購價格採取月度議價方式,故採購數量及採購金額可能隨市場價格產生波動,實際以簽訂的月度《合同執行確認單》為準。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.